EMVision Gets $3M Grant for Brain Injury Scanner
A federal Cooperative Research Centres Projects grant will fund testing of EMVision's portable brain scanner for traumatic brain injury.
Updated on Nov. 20, 2026 in Diseases

EMVision Medical Devices has been awarded a $3 million federal grant to develop and test its portable brain scanner for traumatic brain injury. The grant funds a second clinical application of the First Responder device, which builds on the company's stroke bleed-detection development.
Why it matters
Patients with suspected traumatic brain injury often need hospital CT imaging to confirm whether a bleed is present, particularly when symptoms are subtle. A portable, battery-powered, non-ionising scanner could allow paramedics and clinicians to assess suspected bleeding before hospital arrival.
The grant is EMVision's third CRC-P award, after a separate $3 million grant in 2025, and Australia records an estimated 200,000 traumatic brain injury events a year. Whether the device can reliably detect bleeds against hospital CT or MRI scans has not yet been established, as the project's testing is still to be carried out.
The players
EMVision Medical Devices
An Australian medical device company developing portable brain scanning technology, including the battery-powered First Responder device.
Metro North Hospital and Health Service
A Queensland public health service participating in the project to test the device against hospital imaging.
Titan Prehospital Innovation
A partner organisation participating in the project to evaluate prehospital use of the scanner.
The details
The project will test the First Responder device against hospital CT or magnetic resonance imaging scans from patients with suspected injuries, with Metro North Hospital and Health Service and Titan Prehospital Innovation participating. The device is designed to be carried to patients in the field and is battery-powered and non-ionising.
Timeline
2025: EMVision received a separate $3 million CRC-P grant for the emu Regional Benefits Study.
First quarter 2027: Project work is expected to begin.
First half 2027: The company plans to establish clinical protocols and obtain ethics approvals.
Second half 2027: Clinical study activation is planned.
Big Picture
The award is EMVision's third under the Cooperative Research Centres Projects program, following its separate $3 million grant in 2025 for the emu Regional Benefits Study. It extends the company's use of federal CRC-P funding from its earlier work into a second clinical application of its portable scanner.
If the device is validated, paramedics could assess suspected brain bleeding at the scene rather than waiting for hospital CT imaging. The scanner remains investigational and is not yet approved for detecting traumatic brain injury anywhere.
The takeaway
A portable scanner that can flag brain bleeds before hospital arrival could shorten the time to treatment, but its accuracy must first be proven against hospital imaging. Readers with head injury symptoms should seek medical assessment rather than rely on any field device.
What happens next
Project work is expected to begin in the first quarter of 2027, with clinical study activation planned for the second half of 2027, pending partner agreements being finalised in the coming months.
Further reading
Explore more on Stroke to see how brain bleed detection is being studied.
Source note: This article includes information reported by Small Caps.






